Back to search

Article

Radiological and pathological integration predicts the efficacy of bevacizumab with chemotherapy in colorectal cancer liver metastases

2025-11-18

Abstract excerpt

<title>Abstract</title> <p>While bevacizumab plus chemotherapy is considered the standard therapy for unresectable colorectal cancer liver metastases, a substantial proportion of patients exhibit inadequate responses. This underscores the pressing need for reliable predictive biomarkers. Recent advances in radiomics and pathomics offer robust frameworks for developing sufficiently accurate signatures. However, th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94f83d4a-26b8-50a7-b8ed-0e04fc65f3ef
DOI
10.21203/rs.3.rs-7808212/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Radiological and pathological integration predicts the efficacy of bevacizumab with chemotherapy in colorectal cancer liver metastasesDOI 10.21203/rs.3.rs-7808212/v1
Select a neighboring publication to make it the new centre.